| RRMGX | TIAGX | RRMGX / TIAGX | |
| Total Expense Ratio | 1.31 | 1.36 | 96% |
| Annual Report Gross Expense Ratio | 1.31 | 1.46 | 90% |
| Fund Existence | 24 years | 13 years | - |
| Gain YTD | 1.621 | 37.596 | 4% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 22.4B | 173M | 12,948% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -2.03 | 53.85 | -4% |
| Returns for 3 years | -1.90 | 95.30 | -2% |
| Returns for 5 years | -25.04 | 56.42 | -44% |
| Returns for 10 years | 28.19 | 217.08 | 13% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EDC | 87.27 | 2.45 | +2.89% |
| Direxion Daily MSCI Em Mkts Bull 3X ETF | |||
| PPH | 106.81 | 1.08 | +1.02% |
| VanEck Pharmaceutical ETF | |||
| GBPHKD | 10.38 | 0.06 | +0.60% |
| United Kingdom Pound - Hong Kong Dollar | |||
| AUDUSD | 0.69 | -0.00 | -0.20% |
| Australian Dollar - United States Dollar | |||
| CNYHKD | 1.13 | -0.02 | -1.95% |
| China Yuan - Hong Kong Dollar | |||